cashew
Allergenexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2016 (NCT02769741)
Timeline
2020s
- Jan 1, 2026
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetImmunity, desensitized
cashew
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS3H5U5CX7KO ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07170540 | Phase 2 | Jan 31, 2026 | University of North Carolina at Chapel Hill |
| NCT06930950 | N/A | Sep 13, 2024 | HUS Skin and Allergy Hospital |
| NCT02769741 | N/A | Jan 31, 2016 | Biofortis, Kraft |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biofortis | For profit | 1 | 0 | 1 | 2016 |
| HUS Skin and Allergy Hospital | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Kraft | For profit | 1 | 1 | 1 | 2016 |
| University of North Carolina at Chapel Hill | Academic/Hospital | 1 | 1 | 1 | 2026 |
4 organizations
Page 1 / 1